FDA authorization of AstraZeneca vaccine may hinge on U.S. trial
December 02, 2020 at 15:30 PM EST
The U.S. Food and Drug Administration is unlikely to authorize AstraZeneca’s Covid-19 vaccine candidate prior to the completion of a large U.S. trial in the coming months, a top government adviser said on Wednesday.